BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bosch OG, Seifritz E. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Res Bull 2016;126:47-60. [PMID: 26855327 DOI: 10.1016/j.brainresbull.2016.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Müller CP, Hassan Z. The evaluation of new psychoactive drugs. Brain Res Bull 2016;126:1-2. [PMID: 27235862 DOI: 10.1016/j.brainresbull.2016.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Hassan Z, Bosch OG, Singh D, Narayanan S, Kasinather BV, Seifritz E, Kornhuber J, Quednow BB, Müller CP. Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Front Psychiatry 2017;8:152. [PMID: 28868040 DOI: 10.3389/fpsyt.2017.00152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
3 Asadi L, Saadati Z, Salehpour M. Theoretical evaluation of Al-doped biphenylene nanosheet sensing properties toward gamma-butyrolactone. Struct Chem. [DOI: 10.1007/s11224-022-01964-6] [Reference Citation Analysis]
4 Bosch OG, Havranek MM, Baumberger A, Preller KH, von Rotz R, Herdener M, Kraehenmann R, Staempfli P, Scheidegger M, Klucken T, Seifritz E, Quednow BB. Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans. European Neuropsychopharmacology 2017;27:372-82. [DOI: 10.1016/j.euroneuro.2017.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
5 Krasowski MD. Drug-Assisted Sexual Assaults. Critical Issues in Alcohol and Drugs of Abuse Testing. Elsevier; 2019. pp. 225-36. [DOI: 10.1016/b978-0-12-815607-0.00018-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Bosch OG, Esposito F, Dornbierer D, von Rotz R, Kraehenmann R, Staempfli P, Quednow BB, Seifritz E. Prohedonic properties of gamma-hydroxybutyrate are associated with changes in limbic resting-state functional connectivity. Hum Psychopharmacol 2018;33:e2679. [PMID: 30426556 DOI: 10.1002/hup.2679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Hassanpour A, Ahmadi S, Nezhad PDK, Ebadi A, Sarvestani MRJ, Ebrahimiasl S. Sensing properties of Al- and Si-doped HBC nanostructures toward Gamma-butyrolactone drug: A density functional theory study. Computational and Theoretical Chemistry 2021;1197:113163. [DOI: 10.1016/j.comptc.2021.113163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
8 Bosch OG, Esposito F, Dornbierer D, Havranek MM, von Rotz R, Kometer M, Staempfli P, Quednow BB, Seifritz E. Gamma-hydroxybutyrate increases brain resting-state functional connectivity of the salience network and dorsal nexus in humans. Neuroimage 2018;173:448-59. [PMID: 29524621 DOI: 10.1016/j.neuroimage.2018.03.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Maitre M, Klein C, Mensah-Nyagan AG. A proposed preventive role for Gamma-hydroxybutyrate (Xyrem(R)) in Alzheimer's disease. Alzheimers Res Ther 2016;8:37. [PMID: 27601032 DOI: 10.1186/s13195-016-0205-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
10 Castro AL, Dias AS, Melo P, Tarelho S, Franco JM, Teixeira HM. Quantification of GHB and GHB-GLUC in an 1,4-butanediol intoxication: A case report. Forensic Sci Int 2019;297:378-82. [PMID: 30797604 DOI: 10.1016/j.forsciint.2019.01.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Bosch OG, Esposito F, Havranek MM, Dornbierer D, von Rotz R, Staempfli P, Quednow BB, Seifritz E. Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans. Neuropsychopharmacology 2017;42:2141-51. [PMID: 28561068 DOI: 10.1038/npp.2017.110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
12 Preller KH, Vollenweider FX. Modulation of Social Cognition via Hallucinogens and "Entactogens". Front Psychiatry 2019;10:881. [PMID: 31849730 DOI: 10.3389/fpsyt.2019.00881] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]